← Back to Clinical Trials
Recruiting NCT07615647

NCT07615647 How Video Game Therapy Affects Thinking and Emotions in Older Adults With Cognitive Impairment

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07615647
Status Recruiting
Phase
Sponsor Golden Gamers Go SL
Condition Older Adults (65 Years and Older)
Study Type INTERVENTIONAL
Enrollment 60 participants
Start Date 2026-04-13
Primary Completion 2026-06-15

Eligibility & Interventions

Sex All sexes
Min Age 65 Years
Max Age N/A
Study Type INTERVENTIONAL
Interventions
Videogames masterclassTherapy with videogames

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 60 participants in total. It began in 2026-04-13 with a primary completion date of 2026-06-15.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

Golden Gamers Go is running a study together with Rey Juan Carlos University to better understand how videogames can help older adults, especially those with memory problems or cognitive decline. The study takes place in real care settings, such as day centers, and involves around 45 older participants. Over two months (with a possible follow-up period), participants take part in two to three sessions per week using video games on PlayStation. These are not special "health games," but popular, commercial video games that have been carefully selected and adapted to be easy to use, enjoyable, and meaningful for older adults. The goal is to see whether playing these games can help improve thinking abilities and also how participants feel during the activity - for example, if they are more engaged, motivated, or emotionally positive. This study builds on previous experience where this approach has already shown promising results in increasing participation, motivation, and overall wellbeing. By carrying out this research, Golden Gamers Go aim to better understand how meaningful and enjoyable activities like videogames can support healthier and more active aging.

Eligibility Criteria

Inclusion Criteria: * Older adults with mild to moderate cognitive impairment, able to connect with their environment and participate in group or individual activities, and who agree to take part in the study. Exclusion Criteria: * Severe cognitive impairment with lack of environmental awareness, serious visual limitations that prevent interaction, or any condition causing distress or making participation unsafe.

Contact & Investigator

Central Contact

ALEJANDRO MORILLAS TÉLLEZ, Master

✉ goldengamersmanagers@gmail.com

📞 +34635268124

Principal Investigator

Cristina García Bravo, PhD

STUDY CHAIR

Universidad Rey Juan Carlos

Frequently Asked Questions

Who can join the NCT07615647 clinical trial?

This trial is open to participants of all sexes, aged 65 Years or older, studying Older Adults (65 Years and Older). Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07615647 currently recruiting?

Yes, NCT07615647 is actively recruiting participants. Contact the research team at goldengamersmanagers@gmail.com for enrollment information.

Where is the NCT07615647 trial being conducted?

This trial is being conducted at Madrid, Spain.

Who is sponsoring the NCT07615647 clinical trial?

NCT07615647 is sponsored by Golden Gamers Go SL. The principal investigator is Cristina García Bravo, PhD at Universidad Rey Juan Carlos. The trial plans to enroll 60 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: July 2026  ·  Data Methodology